Swipe om te navigeren naar een ander artikel
Despite the significant impact of Crohn’s disease (CD) on patients’ physical and emotional well-being, no CD-specific patient-reported outcome (PRO) measure is available for determining the efficacy of interventions. The objective of the study was to develop and validate the Crohn’s Life Impact Scale (CLIQ), the first such measure.
Questionnaire content was derived from qualitative interviews with CD patients and face and content validity assessed by cognitive debriefing interviews (CDIs) with patients. A postal survey was conducted to identify the final scale, confirm its unidimensionality and determine reproducibility and construct validity. A subset of the respondents was sent a second questionnaire package 2 weeks after the first. The survey included the CLIQ, Nottingham Health Profile (NHP) and Unidimensional Fatigue Impact Scale (U-FIS).
Content analysis was conducted on the 30 interview transcripts and a draft scale produced. The CDIs indicated that the draft scale was relevant, clear and easy to use. The questionnaire package was completed by 273 CD patients (65.6 % male; aged 16–79 (mean 43.9; SD 15.1) years). Of these, 104 also completed the second package. Rasch analysis confirmed a 27-item unidimensional QoL scale (p < 0.05). Both internal consistency and test–retest reliability were high (0.91). Scores on the CLIQ were related to both physical and emotional impairments (NHP) and to fatigue (U-FIS).
The CLIQ, the first CD-specific PRO, is unidimensional and has excellent psychometric properties. It should prove to be a valuable tool for evaluating the impact of CD and its treatment from the patients’ perspective.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Crohn’s and Colitis UK. Crohn’s Disease information booklet. http://www.crohnsandcolitis.org.uk/Resources/CrohnsAndColitisUK/Documents/Publications/Booklets/Crohns%20Disease.pdf. Accessed 24 July 2013.
Nahon, S., Lahmek, P., Saas, C., Durance, C., Olympie, A., Lesgourgues, B., & Gendre, J. P. (2011). Socioeconomic and psychological factors associated with nonadherence to treatment in inflammatory bowel disease patients: Results of the ISSEO survey. Inflammatory Bowel Diseases, 17(6), 1270–1276. PubMedCrossRef
European Medicines Agency. (2006). Reflection paper on the regulatory guidance for the use of health-related quality of life measures in the evaluation of medicinal products. http://www.ema.europa.eu/ema/pages. Accessed September 3, 2013.
Dür, M., Sadloňová, M., Haider, S., Binder, A., Stoffer, M., Coenen, M., et al. (2014). Health determining concepts important to people with Crohn’s disease and their coverage by patient-reported outcomes of health and wellbeing. Journal of Crohn’s and Colitis, 8(1), 45–55. PubMedCentralPubMedCrossRef
Guyatt, G., Mitchell, A., Irvine, E. J., Singer, J., Williams, N., Goodacre, R., & Tompkins, C. (1989). A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology, 96(3), 804–810. PubMed
van der Linden, W. J., & Hambleton, R. K. (Eds.). (1996). Handbook of modern item response theory. New York: Springer.
Bernklev, T., Moum, B., Moum, T., & Inflammatory Bowel South-Eastern Norway (IBSEN) Group of Gastroenterologists. (2002). Quality of life in patients with inflammatory bowel disease: Translation, data quality, scaling assumptions, validity, reliability and sensitivity to change of the Norwegian version of IBDQ. Scandinavian Journal of Gastroenterology, 37(10), 1164–1174. PubMedCrossRef
Wright, B. D. (1996). Comparing Rasch measurement and factor analysis. Structural Equation Modelling, 3, 3–24. CrossRef
Waugh, R. F., & Chapman, E. S. (2005). An analysis of dimensionality using factor analysis (true-score theory) and Rasch measurement: What is the difference? Which method is better? Journal of Applied Measurement, 6, 80–99. PubMed
Doyal, L., & Gough, I. (1991). A theory of human need. Basingstoke: Macmillan. CrossRef
Hornquist, J. O. (1982). The concept of quality of life. Scandinavian Journal of Social Medicine, 10(2), 57–61. PubMed
Linacre, J. M. (1994). Sample size and item calibration stability. Rasch Measurement Transactions, 7(4), 328.
Hunt, S. M., McEwen, J., & McKenna, S. P. (1986). Measuring health status. London: Croom Helm.
European Group for Quality of Life Assessment and Health Measurement. (1993). European guide to the Nottingham health profile. Brookwood: Brookwood Medical Publications.
van Langenberg, D. R., Della Gatta, P., Warmington, S. A., Kidgell, D. J., Gibson, P. R., & Russell, A. P. (2014). Objectively measured muscle fatigue in Crohn’s disease: correlation with self-reported fatigue and associated factors for clinical application. Journal of Crohn’s and Colitis, 8(2), 137–146. PubMedCrossRef
Rasch, G. (1960). Probabilistic models for some intelligence and attainment tests. Chicago: University of Chicago Press.
Andrich, D., Sheridan, B. S., & Luo, G. (2010). Rumm 2030: Rasch unidimensional measurement models [computer software]. Perth: RUMM Laboratory.
Holland, P. W., & Wainer, H. (Eds.). (1993). Differential item functioning. New Jersey: Lawrence Erlbaum Associates.
Smith, E. V. (2002). Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residuals. Journal of Applied Measurement, 3(2), 205–231. PubMed
Nunally, J. C, Jr. (1978). Psychometric theory (2nd ed.). New York: McGraw-Hill.
Weiner, E., & Stewart, B. (1984). Assessing individuals. Boston: Little Brown.
Kappelman, M. D., Long, M. D., Martin, C., DeWalt, D. A., Kinneer, P. M., Chen, W., et al. (2014). Evaluation of the patient-reported outcomes measurement information system in a large cohort of patients with inflammatory bowel diseases. Clinical Gastroenterology and Hepatology, 12(8), 1315. PubMedCentralPubMedCrossRef
- Assessing quality of life in Crohn’s disease: development and validation of the Crohn’s Life Impact Questionnaire (CLIQ)
Stephen P. McKenna
- Springer International Publishing